Co-Founder/CEO
Kvantify
Kvantify develops a computational drug discovery platform that utilizes proprietary physics-based methods and bespoke algorithms to enhance the quality of compound screening for biotech and pharmaceutical companies. By integrating classical and quantum computing techniques, the platform accelerates research processes and reduces the risks associated with drug development.
- Artificial Intelligence
- Biotechnology
- Quantum Computing
Updated 23 months ago
Funding
Raised to date
$10.8MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Funding rounds are not available yet.
Founders
Product
Problem
Traditional drug discovery processes face challenges in efficiently identifying high-quality drug candidates, often leading to high failure rates and prolonged development timelines. Existing computational methods may lack the accuracy and speed required to effectively screen vast chemical libraries and predict binding affinities.
Solution
Kvantify offers a computational drug discovery platform that leverages physics-based methods and custom algorithms to enhance compound screening for biotech and pharmaceutical companies. By integrating classical and quantum computing techniques, the platform aims to accelerate research, improve the quality of identified compounds, and reduce the risks associated with drug development. The platform, named Koffee, facilitates rapid design-make-test-analyze cycles, enabling researchers to iterate smarter and de-risk their drug discovery process. Kvantify's approach combines physics-based modeling with machine learning integration, anchored in physical principles, to optimize classical methods and develop quantum algorithms for enhanced precision.
Target Audience
The primary target audience includes biotech and pharmaceutical companies involved in small molecule drug discovery, as well as research organizations seeking to improve their compound screening processes.
Features
- Proprietary, high-speed, accurate physics-based methods for compound screening
- Bespoke algorithms to optimize drug discovery pipelines
- Integration of classical and quantum computing techniques
- Koffee platform for binding affinity and kinetics calculations
- Cloud-based platform leveraging HPC infrastructure
- Quantum readiness, ensuring algorithms are prepared for quantum computing advancements
- FAST-VQE, a quantum algorithm for simulating complex chemistry